Importantly, the specificity of the therapeutic anti-OPN antibody is indicated by its co-localization with endogenous OPN in all 3 regions post-ischemic stroke and in healthy animals (Supplementary Fig. 17a–c, online resource). The gene discussed is SPP1; the disease is ischemic stroke.